Peter Goodhand is a senior executive and board member in the health research advancement community.

Career

Starting in the UK in 1980 and moving to North America in 1986, Goodhand had a 20-year career in the global medical technology industry, including international leadership roles with

American Cyanamid American Cyanamid Company was an American manufacturing conglomerate. It began as a fertilizer company and added many additional lines of business before merging with American Home Products in 1994. The combined company sold off most of its di ...

and

Johnson & Johnson Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a c ...

. From 2000 to 2003 he served as the board chair and president of the Canadian Medical Device Technology Association (MEDEC) and presented MEDEC's submission to the Senate Standing Committee on Science and Technology in October 2001. In 2003 he became the founding managing director of the Health Technology Exchange (HTX) and the chairman of the board in 2004. In 2004 he joined the Ontario Division of the

Canadian Cancer Society The Canadian Cancer Society () is Canada's largest national cancer charity and the largest national charitable funder of cancer research in Canada. History The Saskatchewan Medical Association formed Canada's first cancer committee in 1929, whi ...

as its CEO and in 2009 became the national president and CEO. In 2009 he chaired the

Government of Canada The Government of Canada (), formally His Majesty's Government (), is the body responsible for the federation, federal administration of Canada. The term ''Government of Canada'' refers specifically to the executive, which includes Minister of t ...

’s Expert working group on the future of medical isotope production, and in September 2011 was a member of the Canadian delegation to the first UN High Level Meeting on

non-communicable diseases A non-communicable disease (NCD) is a disease that is not transmissible directly from one person to another. NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthriti ...

. From 2012 to 2013 Goodhand played a key role in the creation of a global alliance to accelerate progress in genomic research and medicine and in 2014 became the founding executive director of the

Global Alliance for Genomics and Health (GA4GH) Global may refer to: General *Globe, a spherical model of celestial bodies *Earth, the third planet from the Sun Entertainment * ''Global'' (Paul van Dyk album), 2003 * ''Global'' (Bunji Garlin album), 2007 * ''Global'' (Humanoid album), 198 ...

. As a volunteer he is currently chair of the board HTX; chair of the steering committee of the Occupational Cancer Research Center; Chair of the industry advisory committee and board member of the AGE-WELL National Centre of Excellence; Board Member, MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation); and a member of the Scientific and Medical Advisory board of Global Genes - Allies in Rare Disease.

Awards

2006, The Heather Crowe Award from the

Ontario Government The Government of Ontario () is the body responsible for the administration of the Canadian province of Ontario. The term ''Government of Ontario'' refers specifically to the executive—political ministers of the Crown (the Cabinet/Executive ...

for leadership in advocacy in tobacco control. 2014, The Champions of Hope Award from Global Genes. 2015, The Outstanding Canadian Distinction Award from the Health Charities Coalition of Canada.

References

{{DEFAULTSORT:Goodhand, Peter Living people Year of birth missing (living people) Canadian healthcare chief executives Canadian nonprofit executives